Publikacje Peer reviewed articles (27) Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform Autorzy: Erkko Ylösmäki, Leena Ylösmäki, Manlio Fusciello, Beatriz Martins, Petra Ahokas, Hanne Cojoc, Arttu Uoti, Sara Feola, Anna Kreutzman, Tuuli Ranki, Julia Karbach, Tapani Viitala, Petri Priha, Elke Jäger, Sari Pesonen, Vincenzo Cerullo Opublikowane w: Molecular Therapy - Oncolytics, Issue 20, 2021, Page(s) 459-469, ISSN 2372-7705 Wydawca: Cell Press DOI: 10.1016/j.omto.2021.02.006 Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma Autorzy: Jacopo Chiaro, Henna H.E. Kasanen, Thomas Whalley, Cristian Capasso, Mikaela Grönholm, Sara Feola, Karita Peltonen, Firas Hamdan, Micaela Hernberg, Siru Mäkelä, Hanna Karhapää, Paul E. Brown, Beatriz Martins, Manlio Fusciello, Erkko O. Ylösmäki, Dario Greco, Anna S. Kreutzman, Satu Mustjoki, Barbara Szomolay, Vincenzo Cerullo Opublikowane w: Cancer Immunology Research, Issue 9/8, 2021, Page(s) 981-993, ISSN 2326-6066 Wydawca: American Association for Cancer Research Inc. DOI: 10.1158/2326-6066.cir-20-0814 Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids Autorzy: Firas Hamdan, Erkko Ylösmäki, Jacopo Chiaro, Yvonne Giannoula, Maeve Long, Manlio Fusciello, Sara Feola, Beatriz Martins, Michaela Feodoroff, Gabriella Antignani, Salvatore Russo, Otto Kari, Moon Hee Lee, Petrus Järvinen, Harry Nisen, Anna Kreutzman, Jeanette Leusen, Satu Mustjoki, Thomas G McWilliams, Mikaela Grönholm, Vincenzo Cerullo Opublikowane w: Journal for ImmunoTherapy of Cancer, Issue 9/8, 2021, Page(s) e003000, ISSN 2051-1426 Wydawca: BMJ journal DOI: 10.1136/jitc-2021-003000 Therapeutic Cancer Vaccination with Immunopeptidomics-Discovered Antigens Confers Protective Antitumor Efficacy Autorzy: Karita Peltonen, Sara Feola, Husen M. Umer, Jacopo Chiaro, Georgios Mermelekas, Erkko Ylösmäki, Sari Pesonen, Rui M. M. Branca, Janne Lehtiö, Vincenzo Cerullo Opublikowane w: Cancers, Issue 13/14, 2021, Page(s) 3408, ISSN 2072-6694 Wydawca: Multidisciplinary Digital Publishing Institute (MDPI) DOI: 10.3390/cancers13143408 PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification Autorzy: Sara Feola, Markus Haapala, Karita Peltonen, Cristian Capasso, Beatriz Martins, Gabriella Antignani, Antonio Federico, Vilja Pietiäinen, Jacopo Chiaro, Michaela Feodoroff, Salvatore Russo, Antti Rannikko, Manlio Fusciello, Satu Koskela, Jukka Partanen, Firas Hamdan, Sari M. Tähkä, Erkko Ylösmäki, Dario Greco, Mikaela Grönholm, Tuija Kekarainen, Masoumeh Eshaghi, Olga L. Gurvich, Seppo Ylä-H Opublikowane w: ACS Nano, 2021, ISSN 1936-0851 Wydawca: American Chemical Society DOI: 10.1021/acsnano.1c04371 GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses Autorzy: Firas Hamdan, Beatriz Martins, Michaela Feodoroff, Yvonne Giannoula, Sara Feola, Manlio Fusciello, Jacopo Chiaro, Gabriella Antignani, Mikaela Grönholm, Erkko Ylösmäki, Vincenzo Cerullo Opublikowane w: Molecular Therapy - Methods & Clinical Development, Issue 20, 2021, Page(s) 625-634, ISSN 2329-0501 Wydawca: Cell Press DOI: 10.1016/j.omtm.2021.01.014 Patient-Derived Organoids for Precision Cancer Immunotherapy Autorzy: Mikaela Grönholm, Michaela Feodoroff, Gabriella Antignani, Beatriz Martins, Firas Hamdan, Vincenzo Cerullo Opublikowane w: Cancer Research, Issue 81/12, 2021, Page(s) 3149-3155, ISSN 0008-5472 Wydawca: American Association for Cancer Research DOI: 10.1158/0008-5472.can-20-4026 Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity. Autorzy: Hirvinen M, Capasso C, Guse K, Garofalo M, Vitale A, Ahonen M, Kuryk L, Vähä-Koskela M, Hemminki A, Fortino V, Greco D, Cerullo V. Opublikowane w: Molecular Therapy oncolytics, Issue 23, 2016, Page(s) 3-16002, ISSN 2372-7705 Wydawca: Cell Press DOI: 10.1038/mto.2016.2 Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy Autorzy: Leena Ylösmäki, Beatrice Polini, Sara Carpi, Beatriz Martins, Elena Smertina, Sara Feola, Manlio Fusciello, Karita Peltonen, Paola Nieri, Erkko Ylösmäki, Vincenzo Cerullo Opublikowane w: PLOS ONE, Issue 14/10, 2019, Page(s) e0224072, ISSN 1932-6203 Wydawca: Public Library of Science DOI: 10.1371/journal.pone.0224072 A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines Autorzy: Feola S, Chiaro J, Martins B, Russo S, Fusciello M, Ylösmäki E, Bonini C, Ruggiero E, Hamdan F, Feodoroff M, Antignani G, Viitala T, Pesonen S, Grönholm M, Branca RMM, Lehtiö J, Cerullo V. Opublikowane w: eLIFE, Issue 2022 Mar 22;11, 2022, Page(s) e71156, ISSN 2050-084X Wydawca: eLife Sciences Publications DOI: 10.7554/elife.71156 Oncolytic ImmunoViroTherapy: A long history of crosstalk between viruses and immune system for cancer treatment Autorzy: Feola S., Russo S., Ylösmäki E., Cerullo V. Opublikowane w: Pharmacology & Therapeutics, Issue 236, 2022, Page(s) 108103, ISSN 2468-1016 Wydawca: Elsevier - Sciencedirect DOI: 10.1016/j.pharmthera.2021.108103 Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin Autorzy: Erkko Ylösmäki, Manlio Fusciello, Beatriz Martins, Sara Feola, Firas Hamdan, Jacopo Chiaro, Leena Ylösmäki, Matthew J Vaughan, Tapani Viitala, Prasad S Kulkarni, Vincenzo Cerullo Opublikowane w: Journal for ImmunoTherapy of Cancer, Issue 9/7, 2021, Page(s) e002707, ISSN 2051-1426 Wydawca: BMJ Journals DOI: 10.1136/jitc-2021-002707 Oncolytic Adenovirus Loaded with L-carnosine as Novel Strategy to Enhance the Antitumor Activity Autorzy: Garofalo M, Iovine B, Kuryk L, Capasso C, Hirvinen M, Vitale A, Yliperttula M, Bevilacqua MA, Cerullo V. Opublikowane w: Molecular Cancer Therapeutics, Issue 15(4), 2016, Page(s) 651-660, ISSN 1535-7163 Wydawca: American Association for Cancer Research DOI: 10.1158/1535-7163.mct-15-0559 Pathogens: Our Allies against Cancer? Autorzy: Buonaguro L, Cerullo V. Opublikowane w: Molecular Therapy, Issue Jan 6; 29(1), 2021, Page(s) 10-12, ISSN 1525-0016 Wydawca: Nature Publishing Group DOI: 10.1016/j.ymthe.2020.12.005 β2-Integrin Adhesion Regulates Dendritic Cell Epigenetic and Transcriptional Landscapes to Restrict Dendritic Cell Maturation and Tumor Rejection Autorzy: Guenther C, Faisal I, Fusciello M, Sokolova M, Harjunpää H, Ilander M, Tallberg R, Vartiainen MK, Alon R, Gonzalez-Granado JM, Cerullo V, Fagerholm SC. Opublikowane w: Cancer Immunology Research, Issue 9(11), 2021, Page(s) 1354-1369, ISSN 2326-6074 Wydawca: AACR Journals DOI: 10.1158/2326-6066.cir-21-0094 A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella Autorzy: Fusciello M, Ylösmäki E, Feola S, Uoti A, Martins B, Aalto K, Hamdan F, Chiaro J, Russo S, Viitala T, Cerullo V. Opublikowane w: Molecular Therapy Oncolytics, Issue 2022 Apr 19;25, 2022, Page(s) 137-145, ISSN 2372-7705 Wydawca: Cell Press - Elsevier DOI: 10.1016/j.omto.2022.04.002 A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma Autorzy: Cristian Capasso, Aniket Magarkar, Victor Cervera-Carrascon, Manlio Fusciello, Sara Feola, Martin Muller, Mariangela Garofalo, Lukasz Kuryk, Siri Tähtinen, Lucio Pastore, Alex Bunker, Vincenzo Cerullo Opublikowane w: OncoImmunology, Issue 6/9, 2017, Page(s) e1319028, ISSN 2162-402X Wydawca: Taylor & Francis DOI: 10.1080/2162402X.2017.1319028 Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses Autorzy: Erkko Ylösmäki, Cristina Malorzo, Cristian Capasso, Oona Honkasalo, Manlio Fusciello, Beatriz Martins, Leena Ylösmäki, Antti Louna, Sara Feola, Henrik Paavilainen, Karita Peltonen, Veijo Hukkanen, Tapani Viitala, Vincenzo Cerullo Opublikowane w: Molecular Therapy, Issue 26/9, 2018, Page(s) 2315-2325, ISSN 1525-0016 Wydawca: Nature Publishing Group DOI: 10.1016/j.ymthe.2018.06.008 Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors Autorzy: S. Feola, C. Capasso, M. Fusciello, B. Martins, S. Tähtinen, M. Medeot, S. Carpi, F. Frascaro, E. Ylosmäki, K. Peltonen, L. Pastore, V. Cerullo Opublikowane w: OncoImmunology, 2018, Page(s) e1457596, ISSN 2162-402X Wydawca: Taylor & Francis DOI: 10.1080/2162402x.2018.1457596 Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma Autorzy: Cristian Capasso, Mari Hirvinen, Mariangela Garofalo, Dmitrii Romaniuk, Lukasz Kuryk, Teea Sarvela, Andrea Vitale, Maxim Antopolsky, Aniket Magarkar, Tapani Viitala, Teemu Suutari, Alex Bunker, Marjo Yliperttula, Arto Urtti, Vincenzo Cerullo Opublikowane w: OncoImmunology, Issue 5/4, 2015, Page(s) e1105429, ISSN 2162-402X Wydawca: Taylor & Francis online DOI: 10.1080/2162402X.2015.1105429 Artificially cloaked viral nanovaccine for cancer immunotherapy Autorzy: Manlio Fusciello, Flavia Fontana, Siri Tähtinen, Cristian Capasso, Sara Feola, Beatriz Martins, Jacopo Chiaro, Karita Peltonen, Leena Ylösmäki, Erkko Ylösmäki, Firas Hamdan, Otto K. Kari, Joseph Ndika, Harri Alenius, Arto Urtti, Jouni T. Hirvonen, Hélder A. Santos, Vincenzo Cerullo Opublikowane w: Nature Communications, Issue 10/1, 2019, ISSN 2041-1723 Wydawca: Nature Publishing Group DOI: 10.1038/s41467-019-13744-8 Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site Autorzy: Alessandra Lopes, Sara Feola, Sophie Ligot, Manlio Fusciello, Gaëlle Vandermeulen, Véronique Préat, Vincenzo Cerullo Opublikowane w: Journal for ImmunoTherapy of Cancer, Issue 7/1, 2019, ISSN 2051-1426 Wydawca: BMC part of Spring Nature DOI: 10.1186/s40425-019-0644-7 Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor Autorzy: Flavia Fontana, Manlio Fusciello, Christianne Groeneveldt, Cristian Capasso, Jacopo Chiaro, Sara Feola, Zehua Liu, Ermei M. Mäkilä, Jarno J. Salonen, Jouni T. Hirvonen, Vincenzo Cerullo, Hélder A. Santos Opublikowane w: ACS Nano, Issue 13/6, 2019, Page(s) 6477-6490, ISSN 1936-0851 Wydawca: American Chemical Society DOI: 10.1021/acsnano.8b09613 Exploiting pre-existing immunity to enhance oncolytic cancer immunotherapy Autorzy: Siri Tähtinen, Sara Feola, Cristian Capasso, Netta Laustio, Christianne Groeneveldt, Erkko O Ylösmäki, Leena Ylösmäki, Beatriz Martins, Manlio Fusciello, Marta Medeot, Maria Tagliamonte, Jacopo Chiaro, Firas Hamdan, Karita Peltonen, Tuuli Ranki, Luigi Buonaguro, Vincenzo Cerullo Opublikowane w: Cancer Research, 2020, Page(s) canres.2062.2019, ISSN 0008-5472 Wydawca: American Association for Cancer Research DOI: 10.1158/0008-5472.can-19-2062 Design and application of oncolytic viruses for cancer immunotherapy Autorzy: Erkko Ylösmäki, Vincenzo Cerullo Opublikowane w: Current Opinion in Biotechnology, Issue 65, 2020, Page(s) 25-36, ISSN 0958-1669 Wydawca: Elsevier BV DOI: 10.1016/j.copbio.2019.11.016 Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma Autorzy: Sara Carpi, Beatrice Polini, Stefano Fogli, Adriano Podestà, Erkko Ylösmäki, Vincenzo Cerullo, Antonella Romanini, Paola Nieri Opublikowane w: Expert Review of Molecular Diagnostics, Issue 20/1, 2020, Page(s) 19-30, ISSN 1473-7159 Wydawca: Future Drugs Ltd. DOI: 10.1080/14737159.2020.1696194 Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine Autorzy: Feola S, Russo S, Martins B, Lopes A, Vandermeulen G, Fluhler V, De Giorgi C, Fusciello M, Pesonen S, Ylösmäki E, Antignani G, Chiaro J, Hamdan F, Feodoroff M, Grönholm M, Cerullo V. Opublikowane w: Frontiers Immunology, Issue 14 April 2022; 13, 2022, Page(s) 826164, ISSN 1664-3224 Wydawca: Frontiers DOI: 10.3389/fimmu.2022.826164 Non-peer reviewed articles (1) Uncovering the Tumor Antigen Landscape: What to Know about the Discovery Process Autorzy: Sara Feola, Jacopo Chiaro, Beatriz Martins, Vincenzo Cerullo Opublikowane w: Cancers, Issue 12/6, 2020, Page(s) 1660, ISSN 2072-6694 Wydawca: Multidisciplinary Digital Publishing Institute (MDPI) DOI: 10.3390/cancers12061660 Wyszukiwanie danych OpenAIRE... Podczas wyszukiwania danych OpenAIRE wystąpił błąd Brak wyników
